Skip to Content
Rush-Copley Medical Group
Home > Health & Fitness > Healthwise > Juvenile Idiopathic Arthritis: Features of DMARD and SSARD Drugs
Children who have
juvenile idiopathic arthritis (JIA) are first treated
with nonsteroidal anti-inflammatory drugs (NSAIDs) that
often provide relief and reduce inflammation. NSAIDs are considered the
first-line treatment for JIA. Second-line drug therapy—known interchangeably as
disease-modifying antirheumatic drugs (DMARDs) and as slow-acting antirheumatic
drugs (SAARDs)—for JIA may be recommended when a child continues to have joint
pain, swelling, or both despite rest, exercise, use of NSAIDs, and physical
DMARDs/SAARDs include azathioprine,
cyclosporine, etanercept, methotrexate, and sulfasalazine.
a lot in common.
Although these medicines are often called
"disease-modifying," it has been hard to prove that they truly prevent
long-term joint damage. But they often relieve pain and swelling.
ByHealthwise StaffPrimary Medical ReviewerSusan C. Kim, MD - PediatricsSpecialist Medical ReviewerJohn Pope, MD - Pediatrics
Current as ofSeptember 9, 2014
Current as of:
September 9, 2014
Susan C. Kim, MD - Pediatrics & John Pope, MD - Pediatrics
How this information was developed to help you make better health decisions.
To learn more, visit Healthwise.org
© 1995-2015 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
Retrieving newsletters from the Web service...
Sorry, the newsletter Web service is unavailable at this time.
You have signed up for the selected newsletters.
© Copyright 2015 Rush-Copley Medical Center • 2000 Ogden Avenue; Aurora, IL 60504
Main: 630-978-6200 • Physician Referral & Information: 630-978-6700 or 866-4COPLEY (866-426-7539)